Epidemiology
Etiology
Pathophysiology
Clinical features
Diagnostics
Treatment
Sympathomimetics
- Agents
- Phentermine/topiramate
- Phentermine
- Diethylpropion
- Appetite suppressants
- Contraindicated in patients with:
GLP-1 agonists
- Beneficial in patients with type 2 diabetes
- Increased risk of pancreatitis and gallbladder disease
- May delay gastric emptying, resulting in nausea and vomiting.
Opioid antagonists/norepinephrine-dopamine reuptake inhibitors
Lipase inhibitors
- Orlistat
- Blocks lipase in the bowel, leading to fat malabsorption.
- No longer routinely recommended due to many adverse effects